Glenmark Pharma
-
July 27, 2020, Monday
Nifty needs to hold 11,100 for further upside: Gaurav Garg of CapitalVia
The likelihood of a short-covering move along with addition of fresh position exists only if Nifty breaches 11,200
-
July 25, 2020, Saturday
Covid-19: Favipiravir triggers a price war; new brand launched at Rs 39
According to industry insiders, many more brands are lined up for launch, including one from Cipla
-
July 23, 2020, Thursday
Cheaper favipiravir brand gets nod, to enter market at Rs 59 a pill
The product comes Pune-based Brinton Pharma; Glenmark's FabiFlu is priced at Rs 73 a tablet
-
July 22, 2020, Wednesday
Covid-19 crisis: Glenmark claims 'clinical cure in 4 days' in Phase-3 trial
Firm claims trial results showed 28.6% faster viral clearance in overall population, says drug well tolerated with no major side ...
-
July 21, 2020, Tuesday
FabiFlu cheaper than other drugs to treat Covid-19, claims Glenmark
The company further claimed that since favipiravir was an oral therapy, patients could be treated on an out-patient basis without ...
-
July 21, 2020, Tuesday
Top headlines: Glenmark defends FabiFlu, Covid antibody in Delhi residents
Here are the top headlines of the day
-
July 21, 2020, Tuesday
Glenmark defends pricing of Covid-19 drug FabiFlu, says it is economical
Glenmark also denies making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate Covid-19 patients
-
July 19, 2020, Sunday
Glenmark under fire for over pricing, 'misguided' claims of Covid-19 drug
NCP legislator Amol Kolhe's letter to Health Minister Harsh Vardhan triggers the DCGI to seek details from the Mumbai-based ...
-
July 13, 2020, Monday
Six Indian drug firms that are doing serious business in coronavirus times
The world's race for a coronavirus drug hinges on Indian companies working with their global peers. Business Standard tracks six ...
-
July 01, 2020, Wednesday
Glenmark Pharma falls for second straight day; stock down 8% in 2 days
With the past two day's decline, the share price of Glenmark Pharma has corrected 25 per cent from its 52-week high of Rs 573 ...
